Drug intelligence / Profile preview

lianqin zhenzhu dripping pills

Development stage: Unknown
Lead developer: JiangSu WuZhong Pharmaceutical Development
Administration: Oral

Overview

Lianqin Zhenzhu Dripping Pills (连芩珍珠滴丸) is a proprietary traditional Chinese medicine (TCM) developed and manufactured by Jiangsu Wuzhong Pharmaceutical Group. It is recognized as a nationally exclusive approved product in China. Formulated as an oral dripping pill, it is primarily indicated for clearing heat and detoxification, and is commonly used to treat inflammatory conditions of the upper respiratory tract and oral cavity, such as acute and chronic pharyngitis, tonsillitis, and oral ulcers. The dripping pill dosage form is specifically designed to enhance the dissolution and bioavailability of the active herbal components, providing both systemic and potentially localized therapeutic effects.

Brand names: 连芩珍珠滴丸
Other names: Lianqin Zhenzhu Diwan

Beyond the preview

Go deeper on lianqin zhenzhu dripping pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lianqin zhenzhu dripping pills.

Explore the full profile